These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20949006)

  • 1. Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay.
    Laeyendecker O; Church JD; Oliver AE; Mwatha A; Owen SM; Donnell D; Brookmeyer R; Musoke P; Jackson JB; Guay L; Nakabiito C; Quinn TC; Eshleman SH
    PLoS One; 2010 Oct; 5(10):e13259. PubMed ID: 20949006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.
    Longosz AF; Serwadda D; Nalugoda F; Kigozi G; Franco V; Gray RH; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):339-44. PubMed ID: 24083837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay.
    Longosz AF; Morrison CS; Chen PL; Arts E; Nankya I; Salata RA; Franco V; Quinn TC; Eshleman SH; Laeyendecker O
    J Acquir Immune Defic Syndr; 2014 Apr; 65(4):390-6. PubMed ID: 24583613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.
    Duong YT; Qiu M; De AK; Jackson K; Dobbs T; Kim AA; Nkengasong JN; Parekh BS
    PLoS One; 2012; 7(3):e33328. PubMed ID: 22479384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
    Hauser A; Santos-Hoevener C; Meixenberger K; Zimmermann R; Somogyi S; Fiedler S; Hofmann A; Bartmeyer B; Jansen K; Hamouda O; Bannert N; Kuecherer C
    PLoS One; 2014; 9(6):e98038. PubMed ID: 24892795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison among the BED capture enzyme immunoassay test and AxSYM avidity index assay for determining recent HIV infection and incidence in two Voluntary Counselling and Testing Centres in Northeast Brazil.
    Salustiano DM; Lima KO; Cavalcanti AM; Diaz RS; Lacerda HR
    Braz J Infect Dis; 2014; 18(4):449-53. PubMed ID: 24780363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence Cohort.
    Gonese E; Kilmarx PH; van Schalkwyk C; Grebe E; Mutasa K; Ntozini R; Parekh B; Dobbs T; Duong Pottinger Y; Masciotra S; Owen M; Nachega JB; van Zyl G; Hargrove JW
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):615-627. PubMed ID: 30938164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.
    Wendel SK; Mullis CE; Eshleman SH; Blankson JN; Moore RD; Keruly JC; Brookmeyer R; Quinn TC; Laeyendecker O
    PLoS One; 2013; 8(2):e55525. PubMed ID: 23437058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
    Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.
    Konikoff J; Brookmeyer R; Longosz AF; Cousins MM; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Koblin BA; Justman JE; Hodder SL; Quinn TC; Eshleman SH; Laeyendecker O
    PLoS One; 2013; 8(12):e82772. PubMed ID: 24386116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.
    Laeyendecker O; Gray RH; Grabowski MK; Reynolds SJ; Ndyanabo A; Ssekasanvu J; Fernandez RE; Wawer MJ; Serwadda D; Quinn TC
    AIDS Res Hum Retroviruses; 2019 Apr; 35(4):364-367. PubMed ID: 30560723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
    Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.
    Hanson DL; Song R; Masciotra S; Hernandez A; Dobbs TL; Parekh BS; Owen SM; Green TA
    PLoS One; 2016; 11(4):e0152327. PubMed ID: 27065005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody maturation and viral diversification in HIV-infected women.
    James MM; Laeyendecker O; Sun J; Hoover DR; Mullis CE; Cousins MM; Coates T; Moore RD; Kelen GD; Fowler MG; Kumwenda JJ; Mofenson LM; Kumwenda NI; Taha TE; Eshleman SH
    PLoS One; 2013; 8(2):e57350. PubMed ID: 23460842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High avidity anti-integrase antibodies discriminate recent and non-recent HIV infection: Implications for HIV incidence assay.
    Rikhtegaran Tehrani Z; Azadmanesh K; Mostafavi E; Gharibzadeh S; Soori S; Azizi M; Khabiri A
    J Virol Methods; 2018 Mar; 253():5-10. PubMed ID: 29248529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based study of fertility in women with HIV-1 infection in Uganda.
    Gray RH; Wawer MJ; Serwadda D; Sewankambo N; Li C; Wabwire-Mangen F; Paxton L; Kiwanuka N; Kigozi G; Konde-Lule J; Quinn TC; Gaydos CA; McNairn D
    Lancet; 1998 Jan; 351(9096):98-103. PubMed ID: 9439494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.
    Schüpbach J; Gebhardt MD; Tomasik Z; Niederhauser C; Yerly S; Bürgisser P; Matter L; Gorgievski M; Dubs R; Schultze D; Steffen I; Andreutti C; Martinetti G; Güntert B; Staub R; Daneel S; Vernazza P
    PLoS Med; 2007 Dec; 4(12):e343. PubMed ID: 18052604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries.
    Laeyendecker O; Brookmeyer R; Mullis CE; Donnell D; Lingappa J; Celum C; Baeten JM; Campbell MS; Essex M; de Bruyn G; Farquhar C; Quinn TC; Eshleman SH;
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1177-83. PubMed ID: 22283149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.
    Huik K; Soodla P; Pauskar M; Owen SM; Luo W; Murphy G; Jõgeda EL; Kallas E; Rajasaar H; Avi R; Masciotra S; Lutsar I;
    PLoS One; 2019; 14(5):e0217048. PubMed ID: 31125356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda.
    Mullis CE; Munshaw S; Grabowski MK; Eshleman SH; Serwadda D; Brookmeyer R; Nalugoda F; Kigozi G; Kagaayi J; Tobian AA; Wawer M; Gray RH; Quinn TC; Laeyendecker O
    AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1146-50. PubMed ID: 23641870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.